These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14578542)

  • 1. Mental disorder and substance abuse.
    Moscarelli M; Rupp A
    J Ment Health Policy Econ; 2003 Mar; 6(1):1-2. PubMed ID: 14578542
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality as the driving force for cost-effective psychiatric managed care.
    Roberts B
    J Healthc Qual; 1996; 18(1):4-8; quiz 8, 44. PubMed ID: 10172546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and consequences of dual diagnosis.
    Buckley PF; Brown ES
    J Clin Psychiatry; 2006 Jul; 67(7):e01. PubMed ID: 17107226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quiet epidemic.
    Ryan P
    Calif Hosp; 1993; 7(1):8-11. PubMed ID: 10171358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mental and substance use disorders among Medicaid recipients: prevalence estimates from two national surveys.
    Adelmann PK
    Adm Policy Ment Health; 2003 Nov; 31(2):111-29. PubMed ID: 14756195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Datapoints: Service availability for persons with co-occurring conditions.
    McFarland BH; Gabriel RM
    Psychiatr Serv; 2004 Sep; 55(9):978. PubMed ID: 15345756
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of patients with dual diagnosis.
    McNamara K
    Aust N Z J Psychiatry; 2003 Apr; 37(2):240; author reply 240-2. PubMed ID: 12656968
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-morbid substance misuse and mental health problems: policy and practice in Scotland.
    Baldacchino A
    Am J Addict; 2007; 16(3):147-59. PubMed ID: 17612817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Children and mental health: how can the system be improved?
    England MJ; Cole RF
    Health Aff (Millwood); 1995; 14(3):131-8. PubMed ID: 7498886
    [No Abstract]   [Full Text] [Related]  

  • 10. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward cost-effective care for persons with dual diagnoses.
    Jerrell JM
    J Ment Health Adm; 1996; 23(3):329-37. PubMed ID: 10172689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental illness and substance use: an Australian perspective.
    Munro I; Edward KL
    Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of psychiatric comorbidity. Practical and theoretic considerations.
    Goldsmith RJ
    Psychiatr Clin North Am; 1999 Jun; 22(2):331-49, ix. PubMed ID: 10385937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Substance use and psychiatric symptoms in subjects referred to the drug addiction services by the prefecture].
    Bizzarri JV; Rucci P; Casalboni D; Randi S; Girelli M; Pojer F; Sbrana A
    Epidemiol Psichiatr Soc; 2007; 16(1):73-8. PubMed ID: 17427607
    [No Abstract]   [Full Text] [Related]  

  • 16. Substance abuse and mental illness: unaddressed public health issues for women.
    Baker DR
    J Am Med Womens Assoc (1972); 2001; 56(1):27-8. PubMed ID: 11202070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correctional treatment for co-occurring disorders: results of a national survey.
    Peters RH; LeVasseur ME; Chandler RK
    Behav Sci Law; 2004; 22(4):563-84. PubMed ID: 15282840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual diagnosis demonstration project: treatment outcomes and cost analysis.
    Judd PH; Thomas N; Schwartz T; Outcalt A; Hough R
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():181-92. PubMed ID: 12825761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and growth of managed behavioral health care firms.
    Kihlstrom LC
    Health Aff (Millwood); 1997; 16(4):127-30. PubMed ID: 9248156
    [No Abstract]   [Full Text] [Related]  

  • 20. A health policy paradox: the mind-body disconnect in primary mental healthcare policy. Part I.
    McAllister M
    J Am Acad Nurse Pract; 2005 May; 17(5):163-7. PubMed ID: 15854104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.